Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Measuring disease progression in Parkinson’s disease using administrative health data
FY 2021-22
Summary
Parkinsons disease (PD) is the second most common degenerative brain disease. It leads to shaking, difficulty with walking and moving. Until now, no cures exist. Developing a drug ;from scratch is expensive and time-consuming. ;Drug repurposing is a process by which researchers test a drug already used for a given disease, for a new purpose. To do so, they often use health administrative data. These include millions of individuals and are generated at every encounter with the healthcare system, for example, when visiting a doctors office or the hospital. With these data, researchers can easily test whether a drug is associated with decreased disease progression or severity. One major barrier to use these data in PD is that until now, there is no reliable tool that measures disease progression in health administrative data. My research interest is to develop this tool. I will first develop an algorithm within the health administrative data from Ontario by investigating which codes can reliably represent PD complications. For example, these include dementia and falls, among others. The ;score of progression will be based on the time to onset of these complications, as we expect them to occur earlier in PD compared to controls. Once this algorithm is created, I will validate it using clinical information from real-life PD patients at the movement disorders clinic. This step is to ensure that the algorithm is reliable and represents well the information we are obtaining from health administrative data. This project is important as it will expedite large scale rapid searches to identify drugs associated with reduced PD progression. It will also encourage future clinical trials to test whether these drugs are efficacious and can be approved by governing agencies for PD.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466855
Name
Gros Priti
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Measuring disease progression in Parkinson’s disease using administrative health data
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Disease Modifying Therapies; Disease Progression; Drug Repurposing; Health Administrative Data; Parkinson Disease
Abstract
Parkinsons disease (PD) is the second most common degenerative brain disease. It leads to shaking, difficulty with walking and moving. Until now, no cures exist. Developing a drug ;from scratch is expensive and time-consuming. ;Drug repurposing is a process by which researchers test a drug already used for a given disease, for a new purpose. To do so, they often use health administrative data. These include millions of individuals and are generated at every encounter with the healthcare system, for example, when visiting a doctors office or the hospital. With these data, researchers can easily test whether a drug is associated with decreased disease progression or severity. One major barrier to use these data in PD is that until now, there is no reliable tool that measures disease progression in health administrative data. My research interest is to develop this tool. I will first develop an algorithm within the health administrative data from Ontario by investigating which codes can reliably represent PD complications. For example, these include dementia and falls, among others. The ;score of progression will be based on the time to onset of these complications, as we expect them to occur earlier in PD compared to controls. Once this algorithm is created, I will validate it using clinical information from real-life PD patients at the movement disorders clinic. This step is to ensure that the algorithm is reliable and represents well the information we are obtaining from health administrative data. This project is important as it will expedite large scale rapid searches to identify drugs associated with reduced PD progression. It will also encourage future clinical trials to test whether these drugs are efficacious and can be approved by governing agencies for PD.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gros, Priti
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~